Currently, Tilray is trading 27% higher than its 52-week low of $27.65. The stock is trading at a discount of 88.3% from its 52-week high of $300. READ MORE: https://finance.yahoo.com/m/a721bd03-ab3d-3a69-a3e4-cfcdab84ba96/tilray:-target-price-and.html?.tsrc=rss
What happened Shares of Tilray (NASDAQ: TLRY) are tanking today, down by 10.3% as of 10:40 a.m. EDT. The big drop reflects investors’ disappointment with the Canadian cannabis producer’s second-quarter results , which were announced on Tuesday after the market closed. So what Analysts expected Tilray to post a net loss of $0.25 per share. However, the company actually reported an adjusted net loss…
Canopy Growth reports fiscal first-quarter earnings late. Canopy and other marijuana stocks fell Wednesday after weak Tilray earnings results. READ MORE: https://finance.yahoo.com/m/53627c72-41fa-3d8c-9fad-a7efc7070a20/canopy-growth-earnings-on-tap.html?.tsrc=rss
Canopy Growth reports fiscal first-quarter earnings late. Canopy and other marijuana stocks fell Wednesday after weak Tilray earnings results. READ MORE: https://finance.yahoo.com/m/53627c72-41fa-3d8c-9fad-a7efc7070a20/canopy-growth-earnings-due.html?.tsrc=rss
Tilray’s stock fell after the Canadian cannabis company reported a wider-than-expected loss for the second quarter after the markets closed Tuesday. Here’s what the company reported compared with what Wall Street was expecting, based on a survey of analysts by Refinitiv: Adjusted earnings per share: A loss of 32 cents vs. a loss of 25 cents expected Revenue: $45.9 million…
Analysts expect Tilray to report revenues of $176.6 million and $358.3 million in 2019 and 2020, respectively. Tilray stock rose 8.4% before its earnings. READ MORE: https://finance.yahoo.com/m/250f878a-8051-3d31-8ee1-6c19b30d2ff8/tilray:-analyzing-its-revenue.html?.tsrc=rss
Tilray, Inc. Reports Second Quarter 2019 Financial Results Revenue Rises 371.1% to $45.9 (C$60.9) Million in the Second Quarter Compared to the Prior Year Period Canadian Adult-Use Revenue Nearly Doubles to $15.0 (C$20.0) Million Compared to Prior Quarter Key Investments Made in Europe and the U.S. as Part of Ongoing Focus on Global Expansion NANAIMO, […] READ MORE: https://www.newcannabisventures.com/tilray-reports-strong-cannabis-revenue-growth-in-q2-to-20-million/
Tilray (TLRY) is scheduled to release its second-quarter results today after the market closes. Lately, Tilray stock has been off the radar. READ MORE: https://finance.yahoo.com/m/cf5c8a50-0ed0-3c3f-956b-6aee10afba6e/tilray:-what-to-expect-from.html?.tsrc=rss
Marijuana stocks: Tilray is shipping CBD to help U.S. studies into whether it can help treat alcohol use disorder. Canopy Growth extended a vaping deal. READ MORE: https://finance.yahoo.com/m/bc3c02ee-482d-31ef-9ee4-f5378cb7afdf/marijuana-stock-tilray-tapped.html?.tsrc=rss
Rapid sales growth yields no guarantee of profitability in the cannabis space. READ MORE: https://finance.yahoo.com/news/aurora-canopy-cronos-tilray-profitable-115100831.html?.tsrc=rss
Tilray has managed to successfully import its first bulk supply of medical cannabis oil into the UK. It was a Tilray product, in fact, that was not only confiscated at the border last year – but subsequently sparked media outrage over the denial of the same to one Billy Caldwell, an epileptic child. It was not the only outcry nor…
Canada NewsWire VANCOUVER, July 11, 2019 VANCOUVER, July 11, 2019 /CNW/ – Zenabis Global Inc.’s (TSX:ZENA) (“Zenabis” or the “Company“) wholly-owned subsidiary, Zenabis Ltd., has closed its previously-announced non-dilutive financing via a pre-paid supply agreement with High Park Holdings Ltd. (“High Park”) (the “Supply Agreement”), a wholly-owned subsidiary of Tilray, Inc. (NASDAQ:TLRY) (“Tilray”). Pursuant to the Supply Agreement, High Park advanced $30 million to Zenabis (the “prepaid…